Bayforest Capital Ltd Buys New Shares in Medical Properties Trust, Inc. $MPW

Key Points

• Bayforest Capital Ltd has acquired a new stake in Medical Properties Trust, purchasing 69,175 shares valued at approximately $417,000.
• Wells Fargo & Company and Royal Bank of Canada recently reduced their price targets on Medical Properties Trust from $5.00 to $4.50, reflecting a cautious outlook on the stock.
• The company will pay a quarterly dividend of $0.08 per share on October 9th, representing a 7.0% dividend yield.

Bayforest Capital Ltd bought a new stake in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 69,175 shares of the real estate investment trust's stock, valued at approximately $417,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Charles Schwab Investment Management Inc. raised its position in Medical Properties Trust by 13.4% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 10,020,568 shares of the real estate investment trust's stock valued at $60,424,000 after purchasing an additional 1,182,028 shares during the last quarter. Allianz Asset Management GmbH increased its position in Medical Properties Trust by 43.2% during the 1st quarter. Allianz Asset Management GmbH now owns 7,134,629 shares of the real estate investment trust's stock worth $43,022,000 after purchasing an additional 2,152,861 shares in the last quarter. Northern Trust Corp grew its stake in Medical Properties Trust by 1.5% in the 1st quarter. Northern Trust Corp now owns 6,404,674 shares of the real estate investment trust's stock worth $38,620,000 after acquiring an additional 95,525 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Medical Properties Trust by 11.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,086,848 shares of the real estate investment trust's stock valued at $24,644,000 after acquiring an additional 410,374 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Medical Properties Trust by 4.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,676,474 shares of the real estate investment trust's stock worth $14,522,000 after buying an additional 150,760 shares during the period. Institutional investors and hedge funds own 71.79% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on MPW. Wells Fargo & Company reduced their price target on Medical Properties Trust from $5.00 to $4.50 and set an "underweight" rating on the stock in a research report on Wednesday, August 27th. Royal Bank Of Canada dropped their price target on shares of Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating on the stock in a research note on Monday, June 30th. Zacks Research upgraded Medical Properties Trust from a "strong sell" rating to a "hold" rating in a research report on Wednesday, August 20th. Finally, Wall Street Zen downgraded Medical Properties Trust from a "hold" rating to a "sell" rating in a research report on Saturday, July 5th. Two analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Medical Properties Trust currently has a consensus rating of "Hold" and a consensus price target of $5.58.

Medical Properties Trust Price Performance

Shares of MPW stock opened at $4.60 on Wednesday. Medical Properties Trust, Inc. has a 1 year low of $3.51 and a 1 year high of $6.55. The firm has a market capitalization of $2.77 billion, a price-to-earnings ratio of -1.92 and a beta of 1.35. The company has a current ratio of 2.76, a quick ratio of 2.76 and a debt-to-equity ratio of 2.00. The firm's 50 day moving average is $4.26 and its 200-day moving average is $4.85.

Medical Properties Trust (NYSE:MPW - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). Medical Properties Trust had a negative return on equity of 28.80% and a negative net margin of 155.20%.The firm had revenue of $240.36 million for the quarter, compared to the consensus estimate of $231.90 million. During the same period in the prior year, the business earned $0.23 earnings per share. The company's revenue for the quarter was down 9.8% compared to the same quarter last year. Sell-side analysts forecast that Medical Properties Trust, Inc. will post 0.78 EPS for the current fiscal year.

Medical Properties Trust Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 9th. Stockholders of record on Thursday, September 11th will be issued a dividend of $0.08 per share. The ex-dividend date is Thursday, September 11th. This represents a $0.32 annualized dividend and a dividend yield of 7.0%. Medical Properties Trust's dividend payout ratio is -13.39%.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.